Psoriatic Arthritis News

The use of analgesics is more common in those with psoriasis, specifically those with concomitant psoriatic arthritis, than in the general population, according to a study.

Secukinumab provides early, clinically meaningful, statistically significant and sustained improvements in patient-reported outcomes across all doses, compared with placebo, in active psoriatic arthritis, according to data.

Older adults who took vitamin D with or without omega-3 fatty acid supplementation had a significantly lower rate of autoimmune disease over 5 years compared with those who took placebo, according to findings published in The BMJ.

WAILEA, Hawaii — Guselkumab showed better efficacy in psoriasis skin clearance than most psoriatic arthritis treatments, according to a meta-analysis presented at Maui Derm for Dermatologists.

Approximately 83% to 88% of Canadian patients with immune-mediated inflammatory disease have received two doses of a COVID-19 vaccine, compared with 78% of the general population, according to data published in The Journal of Rheumatology.

Tenosynovitis detected through power Doppler ultrasound predicts rheumatoid and inflammatory arthritis development in patients with clinically suspect arthralgia, according to data published in Arthritis Research & Therapy.

The FDA has approved AbbVie’s risankizumab-rzaa for the treatment of adults with active psoriatic arthritis, expanding its initial indication from plaque psoriasis only.

Psoriatic arthritis patients treated with Bimzelx showed a greater improvement from baseline than those treated with placebo in a phase 3 trial, UCB announced in a company press release.

There are no clinically relevant differences in treatment retention among patients receiving biosimilar or originator biologic disease-modifying antirheumatic drugs as first exposure to that drug, data published in Rheumatology show.